Hematology/Oncology Associates of South Texas

San Antonio, Texas 78229

0 studies enrolling now · 7 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Chronic Lymphocytic Leukemia, Fabry Disease, Hormone Refractory Prostate Cancer, Immune Thrombocytopenic Purpura, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Prostate Cancer

Studies at this site

• Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation — Completed
• A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease — Completed
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed
• Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer — Completed
• A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients — Completed
• A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL) — Completed
• Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) — Completed